Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

49
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
49
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.5K
Cellular Adaptation III: Hyperplasia01:26

Cellular Adaptation III: Hyperplasia

55
Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...
55
Metastasis02:30

Metastasis

5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

3.5K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.5K
Abnormal Proliferation02:23

Abnormal Proliferation

4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fusion gene heterogeneity and kinase enrichment in high-grade serous carcinomas.

Neoplasia (New York, N.Y.)·2026
Same author

Limited clinical utility of mutation-based circulating tumor DNA detection in pseudomyxoma peritonei.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Recently Identified Diagnostic Markers in Effusion Cytology.

Acta cytologica·2026
Same author

FAT1 Is Differentially Expressed in Cancers Affecting the Serosal Cavities.

Pathobiology : journal of immunopathology, molecular and cellular biology·2026
Same author

High prevalence of <i>KRAS</i> and <i>GNAS</i> mutations in pseudomyxoma peritonei underscores opportunities for targeted therapeutic strategies.

Pleura and peritoneum·2026
Same author

The specificity of HEG1 as mesothelioma marker depends on the differential diagnosis.

Virchows Archiv : an international journal of pathology·2026

Related Experiment Video

Updated: May 1, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

8.4K

Cellular Plasticity in Malignant Transformation: Mesothelial Cells.

Claire W Michael1,2, Ben Davidson3,4

  • 1Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA, claire.michael@uhhospitals.org.

Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|April 29, 2026
PubMed
Summary

Recent advancements improve the diagnosis of mesothelial proliferations, distinguishing reactive lesions from tumors like mesothelioma. New tools aid in differentiating mesothelioma from mimics and other cancers, with genetic predispositions now identified.

Keywords:
Ancillary testingBiopsyEffusionMalignant transformationMesotheliumPlasticity

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.6K
Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
09:00

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity

Published on: December 31, 2015

26.4K

Related Experiment Videos

Last Updated: May 1, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

8.4K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.6K
Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
09:00

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity

Published on: December 31, 2015

26.4K

Area of Science:

  • Pathology
  • Oncology
  • Genetics

Background:

  • Mesothelial proliferations encompass a spectrum from reactive changes to benign and malignant tumors.
  • Accurate diagnosis relies on integrating morphology, immunohistochemistry, and molecular testing.
  • Understanding mesothelial cell plasticity is key to classifying these diverse lesions.

Purpose of the Study:

  • To review recent progress in the diagnosis and understanding of mesothelial proliferations.
  • To highlight advancements in differentiating reactive lesions from neoplastic mesothelial tumors.
  • To discuss the identification of genetic factors associated with early-onset mesothelioma.

Main Methods:

  • Review of current literature and diagnostic techniques.
  • Integration of morphological, immunohistochemical, and molecular pathology findings.
  • Discussion of emerging diagnostic tools and genetic analyses.

Main Results:

  • Improved ability to distinguish reactive mesothelial proliferations from true neoplasms.
  • Recognition of mesothelioma in situ as a precursor to invasive mesothelioma.
  • Enhanced differentiation of mesothelial tumors from metastatic carcinomas and other malignancies.
  • Identification and characterization of genetic conditions predisposing to early-onset mesothelioma.

Conclusions:

  • Significant progress has been made in mesothelial pathology, enhancing diagnostic accuracy.
  • Mesothelioma in situ is now a recognized entity, aiding in early detection.
  • Expert multidisciplinary collaboration is crucial for optimal diagnosis and management of mesothelial tumors.